Total Payments
$4,458
2024 Payments
$1,710
Companies
34
Transactions
275
Medicare Patients
2,290
Medicare Billing
$141,961

Payment Breakdown by Category

Food & Beverage$4,458 (100.0%)

Payments by Nature

Nature of Payment Amount Transactions Share
Food and Beverage $4,458 275 100.0%

Top Paying Companies

Company Total Records Latest Year
ABBVIE INC. $1,039 79 $0 (2024)
GlaxoSmithKline, LLC. $488.47 26 $0 (2024)
Novo Nordisk Inc $425.39 31 $0 (2024)
AstraZeneca Pharmaceuticals LP $343.78 11 $0 (2024)
Amgen Inc. $323.81 22 $0 (2024)
PFIZER INC. $263.55 16 $0 (2024)
Novartis Pharmaceuticals Corporation $258.26 16 $0 (2024)
Otsuka America Pharmaceutical, Inc. $182.15 10 $0 (2024)
Merck Sharp & Dohme LLC $156.94 10 $0 (2024)
Axsome Therapeutics, Inc. $116.74 6 $0 (2024)

Payment History by Year

Year Amount Transactions Top Company
2024 $1,710 95 ABBVIE INC. ($410.72)
2023 $1,408 91 ABBVIE INC. ($455.67)
2022 $394.78 25 GlaxoSmithKline, LLC. ($105.12)
2021 $756.86 52 GlaxoSmithKline, LLC. ($131.09)
2020 $176.31 11 AstraZeneca Pharmaceuticals LP ($39.59)
2018 $12.50 1 Merck Sharp & Dohme Corporation ($12.50)

All Payment Transactions

275 individual payment records from CMS Open Payments — Page 1 of 11

Date Company Product Nature Form Amount Type
12/03/2024 ABBVIE INC. VRAYLAR (Drug) Food and Beverage In-kind items and services $10.81 General
Category: NEUROSCIENCE
11/25/2024 ABBVIE INC. VRAYLAR (Drug) Food and Beverage In-kind items and services $5.61 General
Category: NEUROSCIENCE
11/21/2024 Novartis Pharmaceuticals Corporation LEQVIO (Drug), ENTRESTO Food and Beverage In-kind items and services $17.59 General
Category: Cardiology/Vascular Diseases
11/11/2024 ABBVIE INC. VRAYLAR (Drug) Food and Beverage In-kind items and services $10.81 General
Category: NEUROSCIENCE
11/07/2024 ABBVIE INC. UBRELVY (Drug), QULIPTA Food and Beverage In-kind items and services $4.20 General
Category: NEUROSCIENCE
10/22/2024 PFIZER INC. NURTEC ODT (Drug), ZAVZPRET Food and Beverage In-kind items and services $21.99 General
Category: PAIN
10/17/2024 GlaxoSmithKline, LLC. TRELEGY ELLIPTA (Drug) Food and Beverage In-kind items and services $14.27 General
Category: RESPIRATORY
10/14/2024 ABBVIE INC. QULIPTA (Drug) Food and Beverage In-kind items and services $9.12 General
Category: NEUROSCIENCE
10/08/2024 Amgen Inc. Otezla (Drug), Repatha Food and Beverage In-kind items and services $8.35 General
Category: Inflammation
10/07/2024 ABBVIE INC. VRAYLAR (Drug) Food and Beverage In-kind items and services $5.22 General
Category: NEUROSCIENCE
09/26/2024 Salix Pharmaceuticals, a division of Bausch Health US, LLC XIFAXAN (Drug) Food and Beverage In-kind items and services $17.32 General
Category: Gastroenterology
09/23/2024 ABBVIE INC. VRAYLAR (Drug) Food and Beverage In-kind items and services $21.98 General
Category: NEUROSCIENCE
09/11/2024 ABBVIE INC. UBRELVY (Drug) Food and Beverage In-kind items and services $18.82 General
Category: NEUROSCIENCE
09/10/2024 Otsuka America Pharmaceutical, Inc. REXULTI (Drug) Food and Beverage In-kind items and services $18.22 General
Category: PSYCHIATRY
09/10/2024 Novartis Pharmaceuticals Corporation LEQVIO (Drug) Food and Beverage In-kind items and services $13.19 General
Category: Cardiology/Vascular Diseases
09/09/2024 Amgen Inc. Otezla (Drug), Repatha Food and Beverage In-kind items and services $19.68 General
Category: Inflammation
09/04/2024 Takeda Pharmaceuticals U.S.A., Inc. TRINTELLIX (Drug) Food and Beverage In-kind items and services $19.13 General
Category: NEUROSCIENCE
09/03/2024 Mylan Specialty L.P. YUPELRI (Drug) Food and Beverage In-kind items and services $25.22 General
Category: Anticholinergics, Inhaled
08/30/2024 Otsuka America Pharmaceutical, Inc. REXULTI (Drug) Food and Beverage In-kind items and services $15.93 General
Category: PSYCHIATRY
08/30/2024 Lilly USA, LLC ZEPBOUND (Drug) Food and Beverage In-kind items and services $14.03 General
Category: Obesity
08/28/2024 Novartis Pharmaceuticals Corporation ENTRESTO (Drug) Food and Beverage In-kind items and services $15.49 General
Category: Cardiology/Vascular Diseases
08/27/2024 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) CAPLYTA (Drug) Food and Beverage In-kind items and services $23.55 General
Category: PSYCHIATRY
08/27/2024 ABBVIE INC. UBRELVY (Drug), QULIPTA Food and Beverage In-kind items and services $13.44 General
Category: NEUROSCIENCE
08/20/2024 PFIZER INC. NURTEC ODT (Drug), ZAVZPRET Food and Beverage In-kind items and services $21.32 General
Category: PAIN
08/20/2024 ABBVIE INC. QULIPTA (Drug) Food and Beverage In-kind items and services $12.83 General
Category: NEUROSCIENCE

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 11 308 450 $91,449 $32,310
2022 12 459 563 $77,131 $32,005
2021 16 1,415 1,533 $130,317 $70,197
2020 5 108 128 $19,413 $7,449
Total Patients
2,290
Total Services
2,674
Medicare Billing
$141,961
Procedure Codes
44

All Medicare Procedures & Services

44 procedure records from CMS Medicare Utilization — Page 1 of 2

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2023 96 224 $55,552 $18,283 32.9%
G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit Office 2023 44 44 $10,032 $5,285 52.7%
99204 New patient office or other outpatient visit, 45-59 minutes Office 2023 28 28 $10,332 $2,369 22.9%
90694 Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage Office 2023 25 25 $3,375 $1,884 55.8%
87637 Detection test by multiplex amplified probe technique for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (covid-19), influenza virus types a and b, and respiratory syncytial virus Office 2023 11 11 $4,345 $1,538 35.4%
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2023 21 24 $4,080 $1,384 33.9%
G0008 Administration of influenza virus vaccine Office 2023 26 26 $1,040 $744.38 71.6%
0124A Adm sarscv2 bvl 30mcg/.3ml a Office 2023 12 12 $588.00 $458.04 77.9%
83037 Hemoglobin a1c level, by device for home use Office 2023 16 19 $893.00 $180.88 20.3%
83036 Hemoglobin a1c level Office 2023 14 14 $798.00 $133.28 16.7%
81003 Automated urinalysis test Office 2023 15 23 $414.00 $50.60 12.2%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2022 78 175 $43,400 $13,703 31.6%
G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit Office 2022 32 32 $7,296 $3,981 54.6%
0054A Adm sarscv2 30mcg trs-sucr b Office 2022 78 78 $3,510 $2,846 81.1%
0124A Fee covid-19 vac 13 res Office 2022 66 66 $3,206 $2,387 74.4%
0064A Adm sarscov2 50mcg/0.25mlbst Office 2022 51 52 $2,340 $1,898 81.1%
90694 Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage Office 2022 24 24 $3,240 $1,686 52.0%
0134A Fee covid-19 vac 14 res Office 2022 36 36 $1,748 $1,302 74.5%
99204 New patient office or other outpatient visit, 45-59 minutes Office 2022 17 17 $6,273 $1,188 18.9%
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2022 16 21 $3,570 $1,158 32.4%
G0008 Administration of influenza virus vaccine Office 2022 28 29 $1,159 $791.39 68.3%
0004A Adm sarscov2 30mcg/0.3ml bst Office 2022 17 17 $765.00 $626.93 82.0%
G0009 Administration of pneumococcal vaccine Office 2022 16 16 $624.00 $439.40 70.4%
0004A Fee covid-19 vac 1 res Office 2021 495 495 $22,275 $18,419 82.7%
99214 Established patient outpatient visit, total time 30-39 minutes Office 2021 89 191 $44,778 $15,579 34.8%

About Dr. Kyle Lemond, MD

Dr. Kyle Lemond, MD is a Student in an Organized Health Care Education/Training Program healthcare provider based in Evansville, Indiana. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/16/2017. The National Provider Identifier (NPI) number assigned to this provider is 1609303015.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Kyle Lemond, MD has received a total of $4,458 in payments from pharmaceutical and medical device companies, with $1,710 received in 2024. These payments were reported across 275 transactions from 34 companies. The most common payment nature is "Food and Beverage" ($4,458).

As a Medicare-enrolled provider, Lemond has provided services to 2,290 Medicare beneficiaries, totaling 2,674 services with total Medicare billing of $141,961. Data is available for 4 years (2020–2023), covering 44 distinct procedure/service records.

Practice Information

Products in Payments

  • VRAYLAR (Drug) $588.07
  • UBRELVY (Drug) $315.25
  • AIRSUPRA (Drug) $215.74
  • Otezla (Drug) $204.43
  • NURTEC ODT (Drug) $197.15
  • Ozempic (Drug) $192.90
  • TRELEGY ELLIPTA (Drug) $190.04
  • REXULTI (Drug) $182.15
  • SHINGRIX (Biological) $162.64
  • QULIPTA (Drug) $135.78
  • CAPLYTA (Drug) $134.37
  • FARXIGA (Drug) $128.04
  • Auvelity (Drug) $116.74
  • LEQVIO (Drug) $111.33
  • Rybelsus (Drug) $109.66
  • ENTRESTO (Drug) $104.38
  • Aimovig (Biological) $91.13
  • AREXVY (Drug) $71.18
  • XARELTO (Drug) $64.19
  • FLOWTRIEVER CATHETER, S (Device) $61.09

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Student in an Organized Health Care Education/Training Program Doctors in Evansville